Phase Forward Chairman and CEO Robert Weiler Named Ernst & Young Entrepreneur Of The Year® 2010 Award Winner in New England
2010年6月30日 - 12:04AM
ビジネスワイヤ(英語)
Phase Forward (NASDAQ: PFWD), a leading provider of data
management solutions for clinical trials and drug safety, today
announced company Chairman and CEO Robert Weiler has received the
Ernst & Young Entrepreneur Of The Year® 2010 Award in the
Healthcare IT category in New England. According to Ernst &
Young LLP, the award recognizes outstanding entrepreneurs who are
building and leading dynamic, growing businesses. Weiler was
selected by an independent panel of judges, and the award was
presented at a gala event at the Boston Renaissance Waterfront
Hotel on June 24, 2010.
“I congratulate all of the finalists on the hard work and
innovation that have resulted in some of our region’s most
successful businesses,” said Weiler. “All such success stories
involve a committed team, and ours at Phase Forward is no
different. I accept this award on behalf of the Phase Forward team,
our partners and customers, whose dedication inspires me.”
The Ernst & Young Entrepreneur Of The Year awards celebrate
their 24th anniversary this year. The program honors entrepreneurs
who have demonstrated exceptionality in such areas as innovation,
financial performance and personal commitment to their businesses
and communities.
As a New England award winner, Weiler is now eligible for
consideration for the Ernst & Young LLP Entrepreneur Of The
Year 2010 national program. Award winners in several national
categories, as well as the overall national Ernst & Young
Entrepreneur Of The Year award winner, will be announced at the
annual awards gala in Palm Springs, California on November 13,
2010. The awards are the culminating event of the Ernst & Young
Strategic Growth Forum, the nation’s most prestigious gathering of
high-growth, market-leading companies.
About Ernst & Young’s Entrepreneur Of The Year® Awards
Program
Ernst & Young’s Entrepreneur Of The Year® is the world’s
most prestigious business award for entrepreneurs. The award makes
a difference through the unique way it encourages entrepreneurial
activity among those with potential and recognizes the contribution
of people who inspire others with their vision, leadership and
achievement. As the first and only truly global award of its kind,
Ernst & Young Entrepreneur Of The Year® celebrates those who
are building and leading successful, growing and dynamic
businesses, recognizing them through regional, national and global
awards programs in more than 135 cities in 50 countries.
About Phase Forward
Phase Forward is a leading provider of integrated data
management solutions for clinical trials and drug safety. Phase
Forward’s products and services have been utilized in over 10,000
clinical trials involving more than 1,000,000 clinical trial study
participants at over 300 organizations and regulatory agencies
worldwide including: AstraZeneca, Boston Scientific, Dana-Farber
Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration,
GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono,
Novartis, Novo Nordisk, PAREXEL International, Procter &
Gamble, Quintiles, sanofi-aventis, Schering-Plough Research
Institute, Servier, SGS, Tibotec and the U.K. Medicines and
Healthcare Products Regulatory Agency. Additional information about
Phase Forward is available at www.phaseforward.com.
Phase Forward (NASDAQ:PFWD)
過去 株価チャート
から 8 2024 まで 9 2024
Phase Forward (NASDAQ:PFWD)
過去 株価チャート
から 9 2023 まで 9 2024